$AEGR News
Last published 5y ago
- 5y agoERYPNERVNVTAPKI+2Papyrus Therapeutics Inc. Announces Additions to Its Board of DirectorsBusiness WirePapyrus Therapeutics Inc. is delighted to announce that two new members have joined our Board of Directors, Marc Beer as chairman and Professor James Lorens PhD as an independent director. Marc brings more then 30 years of therapeutic development and
- 9y agoAEGRAegerion Pharmaceuticals' (AEGR) CEO Mary Szela on QLT Inc. Strategic Merger Closing Conference (Transcript)Earnings Call Transcripts
- 10y agoAEGRAegerion Pharmaceuticals' (AEGR) CEO Mary Szela on QLT Inc. Strategic Merger Conference (Transcript)Earnings Call Transcripts
- 10y agoAEGRRobbins Arroyo LLP Is Investigating the Officers and Directors of Aegerion Pharmaceuticals, Inc. (AEGR) on Behalf of ShareholdersBusiness WireSAN DIEGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Aegerion Pharmaceuticals, Inc. (NASDAQGS: AEGR) violated their legal obligations to the company and its shareholders in connection with alleged violations of drug marketing requirements, securities laws, and the Health Insurance Portability and Ac ...
- 10y agoAEGRAegerion Pharmaceuticals' (AEGR) CEO Mary Szela on Q1 2016 Results - Earnings Call TranscriptEarnings Call Transcripts
- 10y agoAEGRAegerion Pharmaceuticals (AEGR) Mary J. Szela on Q4 2015 Results - Earnings Call TranscriptEarnings Call Transcripts
- 10y agoAEGRAegerion Pharmaceuticals (AEGR) Q4 2015 Results - Earnings Call WebcastEarnings Call Transcripts
- 11y agoAEGRAegerion (AEGR) Investigated by Former Louisiana Attorney General and Special Prosecutor Richard P. Ieyoub and the Firm of Ieyoub O’Bell & Myers, LLCBusiness WireBATON ROUGE, La.--(BUSINESS WIRE)--Former Attorney General of Louisiana Richard P. Ieyoub and the firm of Ieyoub O’Bell & Myers, LLC (“IOM”) (www.iomcounsel.com) are investigating events at Aegerion Pharmaceuticals, Inc. (AEGR) for possible breaches of fiduciary duties by the management and Board of Directors.
- 12y agoAEGRAEGERION ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Aegerion Pharmaceuticals, Inc.Business WireSAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Johnson & Weaver, LLP has commenced an investigation into whether certain officers and directors of Aegerion Pharmaceuticals, Inc. (Nasdaq: AEGR) violated state or federal laws.
- 12y agoAEGRWolf Haldenstein Announces Investigation of Aegerion Pharmaceuticals, Inc.Business WireNEW YORK--(BUSINESS WIRE)--The law firm of Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating potential federal securities claims against Aegerion Pharmaceuticals, Inc. (“Aegerion” or the “Company”)(NASDAQ:AEGR) and certain of its officers and directors in connection with allegations that the Company made materially false and misleading statements regarding its compliance ...
- 12y agoAEGRGlancy Binkow & Goldberg LLP Announces Investigation on Behalf of Shareholders of Aegerion Pharmaceuticals, Inc.Business WireLOS ANGELES--(BUSINESS WIRE)--Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of shareholders of Aegerion Pharmaceuticals, Inc. (“Aegerion” or the “Company”) (NASDAQ:AEGR) concerning possible violations of federal securities laws. The investigation focuses on certain statements issued by Aegerion concerning the Company’s operations and financial performan ...
- 15y agoAEGRVideo Available: Aegerion Pharmaceuticals’ CEO Marc D. Beer Discusses Business Strategy and ObjectivesBusiness WireCAMBRIDGE, Mass.--(BUSINESS WIRE)--Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, announced the availability of a new video featuring Marc D. Beer, Chief Executive Officer of Aegerion, discussing business strategy and objectives related to the company’s lead ...